LAS VEGAS — Onychomycosis, a stubborn fungal infection of the nail bed, is responsible for half of all nail diseases and presents a tricky challenge when it comes to both diagnosis and treatment. “The ...
Because of increasing antifungal resistance, an accurate diagnosis is important to provide appropriate treatment to patients with onychodystrophy. To identify factors associated with ...
toenail fungus What is the mechanism of action for laser treatment for onychomycosis of the toenails? What is the mechanism of action for laser treatment for onychomycosis of the toenails?—Elizabeth ...
LOS ALTOS, Calif.--(BUSINESS WIRE)--TOPICA Pharmaceuticals, Inc., a privately held biotechnology company, today announced that it’s ready to advance its 10% solution of luliconazole into Phase 3 ...
A study published in the Journal of Drugs in Dermatology compared the clinical cure rates associated with continuous- versus pulse-dose terbinafine regimens for toenail onychomycosis. Sixty patients ...
GREENSBORO, N.C.--(BUSINESS WIRE)--Merz, Inc. (U.S. affiliate of Merz Pharma Group) today announced the completion of the acquisition of ONMEL™ (itraconazole), an azole antifungal that is indicated ...
Asia Pacific, however, is emerging as the fastest-growing region due to urbanization, rising disposable incomes, and higher ...
Toenail fungus might start as a mere cosmetic concern, but this persistent infection can develop into a painful, embarrassing condition when left untreated. Known medically as onychomycosis, fungal ...
A total of 26 RCTs with 8136 patients were included in this network meta analysis. Both oral and topical treatments appear to be safe and effective for treating toenail onychomycosis, according to the ...
Soft rot diseases cause a great deal of damage in agriculture, and turn fruits, vegetables, and mushrooms to mush. By using imaging mass spectrometry together with genetic and bioinformatic techniques ...
Funding to Support Phase 2b/3 Clinical Development Program of Luliconazole for the Treatment of Onychomycosis PALO ALTO, CA, Oct 18, 2011 (MARKETWIRE via COMTEX) -- TOPICA Pharmaceuticals, Inc., a ...